Response to the first wave of pandemic (H1N1) 2009: Experiences and lessons learnt from China

Public Health

Volumn 126, Issue 5, 2012, Pages 427-436

  Liang, W ^a   Feng, L ^b   Xu, C ^b   Xiang, N ^b   Zhang, Y ^b   Shu, Y ^b   Wang, H ^b   Luo, H ^b   Yu, H ^b   Liang, X ^b   Li, D ^b   Lee, C K ^c   Feng, Z ^b   Hou, Y ^b   Wang, Y ^b   Chen, Z ^a   Yang, W ^b  

^a BEIJING HOSPITAL   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

China; Lessons; Pandemic (H1N1) 2009; Response

Indexed keywords

ANTISERUM; ANTIVIRUS AGENT; CHINESE DRUG; INFLUENZA VACCINE; MAXINGSHIGAN YINQIAOSAN; OSELTAMIVIR; UNCLASSIFIED DRUG;

HEALTH CARE; HEALTH SERVICES; INFLUENZA; PUBLIC HEALTH;

2009 H1N1 INFLUENZA; CHINA; CHINESE MEDICINE; CLINICAL DECISION MAKING; DISEASE SEVERITY; DISEASE SURVEILLANCE; DRUG APPROVAL; DRUG EFFICACY; DRUG FATALITY; DRUG INDICATION; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MONITORING; DRUG RESEARCH; DRUG SAFETY; FATALITY; FEVER; FLU LIKE SYNDROME; FUNDING; GEOGRAPHIC DISTRIBUTION; GOVERNMENT REGULATION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PROMOTION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HYGIENE; IMMUNE RESPONSE; INFECTION CONTROL; INFLUENZA VIRUS A H1N1; INFORMATION DISSEMINATION; INTERNATIONAL COOPERATION; MASS COMMUNICATION; MASS IMMUNIZATION; MASS SCREENING; MEDICAL EDUCATION; MEDICAL INFORMATION SYSTEM; NONHUMAN; OUTPATIENT CARE; PATIENT ATTITUDE; PLANNING; PUBLIC HEALTH; REAL TIME POLYMERASE CHAIN REACTION; RESPONSIBILITY; REVIEW; RISK ASSESSMENT; SEASONAL INFLUENZA; SEVERE ACUTE RESPIRATORY SYNDROME; UNSPECIFIED SIDE EFFECT; VIRUS IDENTIFICATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHINA; CIVIL DEFENSE; HUMANS; INFANT; INFECTION CONTROL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; PANDEMICS; PUBLIC HEALTH;

CHINA;

EID: 84860491531     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2012.02.008     Document Type: Review

References (36)

1. Centers for Disease Control and Prevention Swine influenza A (H1N1) infection in two children - Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009, 58:400-402.
2. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
3. World Health Organization. World now at the start of 2009 influenza pandemic. Geneva: World Health Organization; 2009; Available at: [last accessed 23.02.12]. http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html.
4. World Health Organization. Pandemic (H1N1) 2009-update 112. Geneva: World Health Organization; 2010; Available at: [last accessed 23.02.12]. http://www.who.int/csr/don/2010_08_06/en/index.html.
5. Centers for Disease Control and Prevention. CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009-April 10, 2010. Atlanta: CDC; 2010; Available at: [last accessed 23.02.12]. http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm.
6. Viboud C., Miller M., Olson D., Osterholm M., Simonsen L. Preliminary estimates of mortality and years of life lost associated with the 2009 A/H1N1 pandemic in the US and comparison with past influenza seasons. PLoS Curr 2010, 2:RRN1153.
7. Chen H., Wang Y., Liu W., Zhang J., Dong B., Fan X., et al. Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis 2009, 15:1849-1850.
8. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361:1945-1952.
9. Miller E., Hoschler K., Hardelid P., Stanford E., Andrews N., Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010, 375:1100-1108.
10. Wang L., Wang Y., Jin S., Wu Z., Chin D.P., Koplan J.P., et al. Emergence and control of infectious diseases in China. Lancet 2008, 372:1598-1605.
11. Yu H., Shu Y., Hu S., Zhang H., Gao Z., Chen H., et al. The first confirmed human case of avian influenza A (H5N1) in Mainland China. Lancet 2006, 367:84.
12. Cao B., Li X., Shu Y., Jiang N., Chen S.H., Xu X., et al. Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus infection, People's Republic of China, 2009. Emerg Infect Dis 2009, 15:1418-1422.
13. General Administration of Quality Supervision, Inspection and Quarantine of People's Republic of China. 757 confirmed cases with 2009 (H1N1) influenza infection were detected through border entry screening, as of August 23. Beijing: General Administration of Quality Supervision, Inspection and Quarantine of People's Republic of China; 2009; Available at: [last accessed 23.02.12]. http://www.aqsiq.gov.cn/zjxw/zjxw/zjftpxw/200908/t20090826_125223.htm.
14. Zhang Y, Yang P, Liyanage S, Seale H, Deng Y, Pang X, et al. The characteristics of imported cases and the effectiveness of outbreak control strategies of pandemic influenza A (H1N1) in China. [published online ahead of print] Asia Pac J Public Health 2011; Available at: [last accessed 23.02.12]. http://aph.sagepub.com/content/early/2011/05/03/1010539511408285.
15. Huai Y., Lin J., Varma J.K., Peng Z., He J., Cheng C., et al. A primary school outbreak of pandemic 2009 influenza A (H1N1) in China. Influenza Other Respi Virus 2010, 4:259-266.
16. Zhang Y., Gao Y., Fang L., Li Y., Qian Q., Yan L., et al. Pattern on the spread of novel influenza A (H1N1) and quantitative assessment of containment in mainland China. Zhong Hua Liu Xing Bing Xue Za Zhi 2009, 30:1106-1110. [in Chinese].
17. Ministry of Finance of People's Republic of China. Chinese government earmarked 5 billion Yuan on H1N1 response. Beijing: China News Service; 2009; Available at: [last accessed 23.02.12]. http://www.chinanews.com/cj/cj-gncj/news/2009/10-15/1911129.shtml.
18. Cao B., Li X., Mao Y., Wang J., Lu H., Chen Y., et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009, 361:2507-2517.
19. Yu H., Liao Q., Yuan Y., Zhou L., Xiang N., Huai Y., et al. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ 2010, 341:c4779.
20. Yu H., Feng Z., Uyeki T.M., Liao Q., Zhou L., Feng L., et al. Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis 2011, 52:457-465.
21. Wang C., Cao B., Liu Q.Q., Zou Z.Q., Liang Z.A., Gu L., et al. Oseltamivir compared the Chinese traditional therapy Maxingshigan-Yinqiaosan in the treatment of H1N1 influenza. A randomized trial. Ann Intern Med 2011, 155:217-225.
22. World Health Organization. The 5th WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials, 12-13 February 2009, Geneva. Geneva: World Health Organization; 2009; Available at: [last accessed 23.02.12]. http://www.who.int/vaccine_research/diseases/influenza/meeting_120209/en/.
23. Li C., Shao M., Cui X., Song Y., Li J., Yuan L., et al. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China. Biologicals 2010, 38:284-289.
24. Zhu F., Wang H., Fang H., Yang J., Lin X., Liang X., et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009, 361:2414-2423.
25. Liang X., Wang H., Wang J., Fang H., Wu J., Zhu F., et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010, 375:56-66.
26. Stone R. Swine flu outbreak. China first to vaccinate against novel H1N1 virus. Science 2009, 325:1482-1483.
27. Liang X.F., Li L., Liu D.W., Li K.L., Wu W.D., Zhu B.P., et al. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. N Engl J Med 2011, 364:638-647.
28. Wu J., Xu F., Lu L., Lu M., Miao L., Gao T., et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med 2010, 363:2416-2423.
29. Ministry of Health of People's Republic of China. Briefing reports on pandemic (H1N1) 2009 influenza vaccination in China. Beijing:Ministry of Health of People's Republic of China; 2010; Available at: [last accessed 23.02.12]. http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohjbyfkzj/s3578/201004/46607.htm.
30. Feng L., Mounts A.W., Feng Y., Luo Y., Yang P., Feng Z., et al. Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009. Vaccine 2010, 28:6778-6782.
31. Lin Y., Huang L., Nie S., Liu Z., Yu H., Yan W., et al. Knowledge, attitudes and practices (KAP) related to the pandemic (H1N1) 2009 among Chinese general population: a telephone survey. BMC Infect Dis 2011, 11:128.
32. Seale H., Kaur R., Wang Q., Yang P., Zhang Y., Wang X., et al. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China. Vaccine 2011, 29:1605-1610.
33. Xu C., Bai T., Iuliano A.D., Wang M., Yang L., Wen L., et al. The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS One 2011, 6:e17919.
34. China Youth Daily. Over 80% of Chinese were satisfied with pandemic H1N1 influenza response. Beijing: Guangming Daily Newspaper; 2009; Available at: [last accessed 23.02.12]. http://www.gmw.cn/content/2010-01/14/content_1037723.html.
35. National Bureau of Statistics of People's Republic of China. Statistical data by quarter. Beijing: National Bureau of Statistics of People's Republic of China; 2010; Available at: [last accessed 23.02.12]. http://www.stats.gov.cn/tjsj/jidusj/.
36. National Tourism Administration of People's Republic of China. Summary of incomming travellers. Beijing: National Tourism Administration of People's Republic of China; 2010; Available at: [last accessed 23.02.12]. http://www.cnta.com/html/rjy/index_9.html.